CIK: 0001346824 · Show all filings
Period: Q1 2023 (← Previous) (Next →)
Filing Date: May 15, 2023
Total Value ($000): $4,417,403 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ASND | ASCENDIS PHARMA A/S | 6,957,179 | $745,949 | 16.9% | $73.22 | — | COM | 04351P101 |
| PCVX | VAXCYTE INC | 7,291,254 | $273,276 | 6.2% | $34.37 | +23.4% | COM | 92243G108 |
| — | DICE THERAPEUTICS INC | 7,856,612 | $225,092 | 5.1% | $31.90 | — | COM | 23345J104 |
| — | 89BIO INC | 11,416,948 | $173,880 | 3.9% | $16.58 | — | COM | 282559103 |
| — | AEROVATE THERAPEUTICS INC | 8,263,982 | $166,685 | 3.8% | $22.83 | — | COM | 008064107 |
| BIIB | BIOGEN INC | 532,892 | $148,160 | 3.4% | $216.32 | +27.9% | COM | 09062X103 |
| — | VERONA PHARMA PLC | 6,317,990 | $126,865 | 2.9% | $7.68 | — | COM | 925050106 |
| CTKB | CYTEK BIOSCIENCES INC | 13,381,054 | $122,972 | 2.8% | $20.70 | -48.0% | SPONSORED ADR | 23285D109 |
| — | VOR BIOPHARMA INC | 22,748,880 | $122,389 | 2.8% | $24.47 | — | COM | 929033108 |
| LEGN | LEGEND BIOTECH CORP | 2,436,223 | $117,475 | 2.7% | $41.17 | — | COM | 52490G102 |
| TYRA | TYRA BIOSCIENCES INC | 7,236,454 | $116,290 | 2.6% | $19.11 | -37.8% | COM | 90240B106 |
| JANX | JANUX THERAPEUTICS INC | 8,670,644 | $104,915 | 2.4% | $22.27 | -25.3% | COM | 47103J105 |
| PEPG | PEPGEN INC | 8,131,952 | $99,454 | 2.3% | $11.15 | +40.4% | COM | 713317105 |
| RNAM | AVIDITY BIOSCIENCES INC | 6,416,998 | $98,501 | 2.2% | $16.99 | +29.5% | COM | 05370A108 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 5,516,067 | $98,407 | 2.2% | $24.11 | +4.2% | COM | 76243J105 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 7,040,622 | $94,133 | 2.1% | $18.13 | +7.7% | COM | 23954D109 |
| — | BELLUS HEALTH INC NEW | 12,643,574 | $91,034 | 2.1% | $8.28 | — | COM | 07987C204 |
| — | CUREVAC N V | 12,245,955 | $85,354 | 1.9% | $6.97 | — | SPONSORED ADS | N2451R105 |
| — | IMMUNOGEN INC | 21,853,958 | $83,919 | 1.9% | $5.49 | — | CLASS A COM | 45253H101 |
| WVE | WAVE LIFE SCIENCES LTD | 17,202,009 | $74,485 | 1.7% | $8.85 | -48.3% | COM | Y95308105 |
| — | INHIBRX INC | 3,853,867 | $72,722 | 1.6% | $24.64 | — | COM | 45720L107 |
| GERN | GERON CORP | 31,544,806 | $68,452 | 1.5% | $2.29 | +24.1% | ADS | 374163103 |
| COGT | COGENT COMMUNICATIONS HLDGS | 5,999,481 | $64,734 | 1.5% | $13.27 | -3.6% | COM | 19240Q201 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 1,734,972 | $62,424 | 1.4% | $44.65 | -3.4% | COM | 15117B202 |
| ACRV | ACRIVON THERAPEUTICS INC | 4,810,508 | $61,045 | 1.4% | $12.69 | +32.3% | COM | 004890109 |
| — | ITEOS THERAPEUTICS INC | 4,417,259 | $60,119 | 1.4% | $24.67 | — | SPONSORED ADR | 46565G104 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 4,000,000 | $53,040 | 1.2% | $9.95 | +26.8% | COM | N62509109 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 2,007,946 | $51,082 | 1.2% | $25.89 | +23.8% | COM | 92790C104 |
| RXST | RXSIGHT INC | 3,052,796 | $50,921 | 1.2% | $13.76 | +2.6% | ORDINARY SHARES | 78349D107 |
| MLYS | MINERALYS THERAPEUTICS INC | 3,178,476 | $49,775 | 1.1% | $16.83 | 0.0% | COM | 603170101 |
| PLRX | PLIANT THERAPEUTICS INC | 1,762,000 | $46,869 | 1.1% | $28.47 | 0.0% | COM | 729139105 |
| ELVN | ENLIVEN THERAPEUTICS INC | 2,122,465 | $46,482 | 1.1% | $20.34 | 0.0% | COM | 29337E102 |
| GHRS | GH RESEARCH PLC | 5,581,161 | $44,593 | 1.0% | $17.97 | -48.9% | COM | G3855L106 |
| ABOS | ACUMEN PHARMACEUTICALS INC | 9,770,773 | $39,669 | 0.9% | $16.64 | -68.6% | SPONSORED ADS | 00509G209 |
| CLYM | ELIEM THERAPEUTICS INC | 13,150,849 | $38,137 | 0.9% | $20.66 | -83.3% | COM | 28658R106 |
| ANTX | AN2 THERAPEUTICS INC | 3,773,517 | $37,245 | 0.8% | $15.13 | -26.5% | COM | 037326105 |
| — | ALPINE IMMUNE SCIENCES INC | 4,688,115 | $36,192 | 0.8% | $7.23 | — | COMMON STOCK | 02083G100 |
| ACRS | ACLARIS THERAPEUTICS INC | 4,398,453 | $35,583 | 0.8% | $13.86 | -8.4% | COM | 00461U105 |
| — | ICOSAVAX INC | 5,963,565 | $34,589 | 0.8% | $28.89 | — | COM | 45114M109 |
| FULC | FULCRUM THERAPEUTICS INC | 11,609,704 | $33,088 | 0.7% | $7.35 | +21.9% | COM | 359616109 |
| — | HILLEVAX INC | 1,760,019 | $29,093 | 0.7% | $10.93 | — | COM | 43157M102 |
| NKTX | NKARTA INC | 7,805,129 | $27,708 | 0.6% | $24.86 | -80.9% | COM | 65487U108 |
| — | KINNATE BIOPHARMA INC | 4,264,144 | $26,651 | 0.6% | $35.29 | — | COM | 49705R105 |
| — | NANOSTRING TECHNOLOGIES | 2,457,273 | $24,327 | 0.6% | $10.06 | — | SHS | 63009R109 |
| SPRY | ARS PHARMACEUTICALS INC | 3,009,678 | $19,593 | 0.4% | $6.49 | +18.4% | COM | 82835W108 |
| RCKT | ROCKET PHARMACEUTICALS INC | 1,131,775 | $19,387 | 0.4% | $34.21 | -42.8% | COM | 77313F106 |
| TNYA | TENAYA THERAPEUTICS INC | 6,067,483 | $17,292 | 0.4% | $7.47 | -62.4% | COM | 87990A106 |
| DSGN | DESIGN THERAPEUTICS INC | 2,971,231 | $17,144 | 0.4% | $27.75 | -73.0% | COM | 25056L103 |
| SLDB | SOLID BIOSCIENCES INC | 3,426,286 | $16,241 | 0.4% | $6.55 | -8.3% | COM | 83422E204 |
| HOWL | WEREWOLF THERAPEUTICS INC | 6,144,881 | $15,977 | 0.4% | $10.47 | -71.5% | COM | 95075A107 |
| CELC | CELCUITY INC | 1,400,001 | $14,350 | 0.3% | $10.24 | +7.1% | COM | 15102K100 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 3,370,506 | $9,909 | 0.2% | $11.52 | -69.0% | COM | 30233G209 |
| — | CONNECT BIOPHARMA HLDGS LTD | 6,991,003 | $6,990 | 0.2% | $19.09 | — | CLASS A ORD SHS | 207523101 |
| BDTX | BLACK DIAMOND THERAPEUTICS I | 2,589,904 | $4,895 | 0.1% | $30.22 | -92.4% | COM | 09203E105 |
| WHWK | AADI BIOSCIENCE INC | 590,218 | $4,273 | 0.1% | $14.25 | -25.0% | COM | 00032Q104 |
| — | SATSUMA PHARMACEUTICALS INC | 5,914,252 | $4,131 | 0.1% | $13.11 | — | ORD SHS | 80405P107 |
| — | FUSION PHARMACEUTICALS INC | 659,992 | $2,488 | 0.1% | $3.01 | — | COM | 36118A100 |
| NAMSW | NEWAMSTERDAM PHARMA COMPANY | 333,333 | $613 | 0.0% | $0.87 | — | *W EXP 11/22/202 | N62509117 |
| ENTX | ENTERA BIO LTD | 295,966 | $343 | 0.0% | $3.70 | -73.0% | COM | M40527109 |